Statistics about Health, Pharma & Medtech in United States
Statistics
- Relationship improvement due to hearing aids in select developed countries 2014-2015
- Types of chatbots used in medical practices in the U.S. in 2023
- U.S. adults with hearing trouble who had used a hearing aid 2014, by age
- Value of medical device imports from the U.S. to Taiwan 2014-2019
- Annual change in U.S. hearing aid sales 2007-2022
- Preferred methods of choice for sharing wearable health data in the U.S. 2023
- Elderly adults in the U.S. with a mobility aid who had fallen 2015, by insurance
- Likelihood of choosing a doctor who uses wearable data in the U.S. 2023
- Doctors' trust in chatbots' abilities in the U.S. in 2023
- Reasons for sharing data from personal devices with doctors in the U.S. 2023
- Main medical chatbot applications for patients in the U.S. in 2023
- Medical exoskeleton market worldwide in 2017 and 2023
- Size of U.S. orthopedic braces and support systems market by product 2015-2025
- Size of U.S. orthopedic braces and support systems market 2015-2025
- Most prescribed hearing aid brands or manufacturers among U.S. audiologists 2018
- Possible cost savings using 3D-printed guides in surgery 2019
- Safety and independence due to hearing aids in select developed countries 2014-2015
- Injuries from crutches, canes and walkers in the U.S in 2010, by diagnosis
- Injuries from crutches, canes and walkers in the U.S in 2010, by body part injured
- Elderly adults in the U.S. with a mobility aid who had fallen 2015, by age
- Reasons for nonuse among elderly adults in the U.S. with a mobility aid 2015
- Injuries from crutches, canes and walkers in the U.S 2002-2010
- Possible time saved using 3D-printed guides in surgery 2019
- Yearly cost savings using 3D-printed guides in surgery 2019, by specialty
- Yearly time savings using 3D-printed guides in surgery 2019, by specialty
- Improved life quality due to hearing aids in select developed countries 2014-2015
- Potential biosimilars savings in EU5 countries and the U.S. 2016-2020
- U.S. metropolitan areas by employment in research and medical laboratories 2021
- Biotech vs. Web 2.0 share of total U.S. venture investment 2005-2010
- U.S. bioscience venture capital investments 2009-2021
- U.S. states with large employment in drugs and pharmaceuticals 2021
- U.S. bioscience-related patents by segment 2018-2021
- Top U.S. states based on academic bioscience R&D expenditure 2020
- Biosimilars approved for marketing Europe vs U.S. 2022 by year since approval
- Net loss Intellia Therapeutics 2014-2023
- Revenue of Intellia Therapeutics 2015-2023
- R&D expenses of Intellia Therapeutics 2014-2023
- Total assets of Intellia Therapeutics 2014-2023
- Physician office payment for biosimilars in Medicare Part B 2022
- U.S. bioscience employment distribution 2021 by subsector
- U.S. specialists and familiarity with biosimilars 2021
- Number of biosimilar drugs becoming available United States 2015-2022
- Comparison WAC of Herceptin vs biosimilars in the U.S. Q2 2020
- Comparison ASP Herceptin vs biosimilars in the U.S. Q2 2020
- Comparison WAC of Remicade vs biosimilars in the U.S. as of Q3 2020
- Comparison ASP of Remicade vs biosimilars in the U.S. Q3 2020
- Commercial leaders vs. other companies in U.S. biotech 2016
- Opinion on drug spending reduction due to biosimilars for specialty drugs 2017-2020
- Value of biological product manufacturing shipments 1998-2011
- U.S. average annual wages per employee by industry 2021
- U.S. bioscience establishments totals 2018-2021
- U.S. bioscience employment by subsector 2021
- Select M&As involving U.S. and European biotech companies 2022
- Market capitalization of U.S. biotech companies by region 2021
- Size of the U.S. vaccine market by age 2014-2024
- Price increase of select biotech drugs in the U.S. during January 2021
- U.S. public biotech companies revenue by region 2021
- Public U.S. biotech companies R&D spending by region 2021
- IPOs in U.S. and Europe biotechnology industry 2000-2022
- Venture capital in U.S. and Europe biotechnology industry 2015-2022
- Total raised capital in U.S. and Europe biotechnology industry 2015-2022
- Largest biotech financing deals in the United States in Q4 2020, by company
- Number of public biotech companies in the U.S. 2021 by region
- U.S. industrial biotech-related sales in chemicals
- Value of top U.S. biotech IPOs 2022
- Alliances U.S. and Europe biotech companies by total potential value 2022
- Number of FDA approvals for CAR-T cell therapies 2012-2024
- Amount of top U.S. biotech venture financings 2022
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- COVID-19 vaccine and willingness among U.S. adults Dec 2020 - Apr 2022
- Annual salaries of U.S. biotech sales representatives in the U.S. 2016-2019
- Size of the total U.S. vaccine market 2014-2024
- United States biotech financing data 2015-2020
- U.S. bioscience employment totals 2018-2021
- Cumulative potential biosimilars market in EU5 countries and the U.S. 2016-2020
- Number of U.S. bioscience establishments by subsectors 2021
- Medical cannabis market size in the United States 2019-2025
- Legal cannabis industry investments on biotech in the U.S. 2015-2017
- CBD pharmaceuticals market size in the United States 2019-2026
- Cell-free DNA based cancer diagnostic and screening market US vs. world 2020
- Medical cannabis market size in the United States by type 2019 and 2025
- CBD market size distributed by pharmacies and practitioners in the U.S. 2019-2026
- Major biologics to lose patent protection 2015-2020 by EU5 and U.S. revenue
- Top drugs advertised to consumers in the U.S. in 2018, by total DTCA spending
- Biotech market cap change since flotation in U.S. companies 2019
- mRNA vaccine and therapy market value U.S. 2020-2030
- U.S. biotech companies market capitalization 1994-2016
- Disparities median price Lantus by select countries 2019
- U.S. biological product manufacturing gross output 1998-2016
- Changes in biotech companies market capitalization in the U.S. 2012-2016
- Market cap CAGR of biotech companies in the U.S. 2012-2016
- Market cap CAGR of biotech companies in Europe 2012-2016
- IPO pricing in U.S. biotechnology industry 2014-2016
- U.S. veterinary medicine and vaccines import and export value in 2016
- First biosimilar marketing initiatives by MCOs in U.S. 2015
- YTD stock performance of biopharma companies working on COVID March 2020
- Sales per employee of select U.S. biotech and drugs companies Q3 2023
- CAGR of the biosimilars market in Europe and the United States 2018-2025
- BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
- Gross profit margin of select U.S. biotech and drugs companies Q3 2023